Bormioli Pharma acquired by Gerresheimer

Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has successfully completed the acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group announced in May 2024. The closing was preceded by the fulfillment of customary closing conditions.

Bormioli Pharma has a portfolio of pharmaceutical primary packaging made of glass and plastic as well as closure solutions, accessories and dosing systems that is complementary to Gerresheimer.

With this acquisition, Gerresheimer strengthens its European footprint with additional production sites and underpins its market position as a leading full-service provider and global partner for the pharma and biotech industries.

Gerresheimer expects the acquisition to be accretive to the Group's Adj. EBITDA margin and Adj. EPS from the first year onwards through synergies. On February 26, 2025, Gerresheimer will publish a new guidance for the combined company together with the results for the financial year 2024.

"Following the successful completion of the acquisition, we can now focus on the integration of Bormioli Pharma into the Gerresheimer Group," explains Dietmar Siemssen, CEO of Gerresheimer AG. "We are convinced that our customers will benefit from the expansion of the product portfolio and new, integrated systems and solutions."